Position in IFRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$260,166
-$33,758 QoQ
Shares Held
291,014
0.0% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#9
of 35 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in IFRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T3 Companies, LLC holds $2,219,191 across 9 Biotechnology names. IFRX ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
5,700 | $634,695 | |
| 2 | VYNE |
VYNE Therapeutics Inc.
|
945,000 | $565,110 | |
| 3 | SEER |
Seer, Inc.
|
170,962 | $287,216 | |
| 4 | IFRX |
InflaRx N.V.
This page
|
291,014 | $260,166 | |
| 5 | NRXS |
Neuraxis, INC
|
29,921 | $221,415 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
33,800 | $97,344 | |
| 7 | CBUS |
Cibus, Inc.
|
48,500 | $96,030 | |
| 8 | COCP |
Cocrystal Pharma, Inc.
|
51,500 | $52,015 |
All Filings in IFRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $260,166 | 291,014 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $293,924 | 291,014 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||